Condition: Marburg Virus Disease · Sponsor: International AIDS Vaccine Initiative
A Phase 1 Randomized, Observer Blind, Placebo-controlled, Dose-escalation and dose expansion Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health
This description comes directly from the study's public registry record.
Johannes Beeslaar, MD · 212-328-7459 · JBeeslaar@iavi.org
Always discuss trial participation with your own doctor first.
| George Washington University | Washington D.C., District of Columbia, United States | Recruiting |
| Johnson County Clin-Trials | Lenexa, Kansas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07425821